0B68 Dalakas, Marinos - Thomas Jefferson University - Thomas Jefferson University

Marinos C. Dalakas, MD, FAAN

Contact Dr. Dalakas

901 Walnut Street
4th Floor
Philadelphia, PA 19107

(215) 955 -7865
(215) 955-9976 fax

Most Recent Peer-reviewed Publications

  1. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis
  2. Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4
  3. Pathogenesis of immune-mediated neuropathies
  4. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  5. Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse
  6. Inflammatory muscle diseases inflammatory muscle diseases
  7. Lower extremity peak force and gait kinematics in individuals with inclusion body myositis
  8. Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
  9. Reliability of the adult myopathy assessment tool in individuals with myositis
  10. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders
  11. Intravenous immunoglobulin in neurology-mode of action and clinical efficacy
  12. The author replies
  13. Immunotherapy-responsive limbic encephalitis with antibodies to glutamic acid decarboxylase
  14. Pathogenesis of immune-mediated neuropathies
  15. IVIg in the chronic management of myasthenia gravis: Is it enough for your money?
  16. Mechanistic effects of IVIg in neuroinflammatory diseases: Conclusions based on clinicopathologic correlations
  17. 7th International immunoglobulin conference: Interlaken leadership awards
  18. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: A controlled study
  19. 7th International Immunoglobulin Conference: Interlaken Leadership Awards
  20. Are repeated single-limb heel raises and manual muscle testing associated with peak plantar-flexor force in people with inclusion body myositis?